VTGN - VistaGen Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$0.95
DETAILS
HIGH:
$1.00
LOW:
$0.90
MEDIAN:
$0.95
CONSENSUS:
$0.95
UPSIDE:
64.87%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -11517.1% |
| EBITDA Margin | -11386.4% |
| Operating Margin | -11517.1% |
| Pretax Margin | -10578.4% |
| Cont. Ops Margin | -10579.8% |
| Net Margin | -10579.8% |
| Bottom Line Margin | -10579.8% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 6.51 |
| Quick Ratio | 6.51 |
| Solvency Ratio | -3.640 |
| Cash Ratio | 5.32 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-1.49
Peers avg: 21.5
|
| PEG Ratio | -0.15 |
| Forward PEG | -0.15 |
| Price/Book | 1.09 |
| Price/Sales | 157.98 |
| Price/FCF | -1.82 |
| Price/Op Cash Flow | -1.82 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0179 |
| Debt/Equity | 0.0214 |
| Debt/Capital | 0.0210 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.20 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.01 |
| Operating Cash Flow Ratio | -3.338 |
| Operating Cash Flow/Sales | -8661.9% |
| Free Cash Flow/Operating Cash Flow | 100.5% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -27.90 |
| Capital Expenditure Coverage | -220.40 |
| Dividend + Capital Expenditure Coverage | -220.40 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.02 |
| EPS | -1.674 |
| Debt/Share | 0.0491 |
| Cash/Share | 2.62 |
| Book Value/Share | 2.29 |
| Tangible BV/Share | 2.29 |
| Equity/Share | 2.29 |
| Operating Cash Flow/Share | -1.371 |
| Capital Expenditure/Share | 0.006 |
| FCF/Share | -1.377 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.918 |
| Price/Fair Value | 1.09 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | -0.0% |
| Enterprise Value Multiple | -0.20 |